The Keto HDAC Myth — How One Paper Misled Millions for a Decade
- A 2013 Science paper claimed beta-hydroxybutyrate (BHB), the primary ketone body produced during ketosis, was a potent histone deacetylase (HDAC) inhibitor with powerful epigenetic benefits — this claim became the foundation of the keto movement's health narrative
- A devastating 2019 head-to-head comparison in Scientific Reports found that BHB shows no detectable HDAC inhibition in vitro or in vivo, while butyrate (a different molecule produced by gut bacteria) demonstrates robust HDAC-inhibiting activity
- The bitter irony: ketogenic diets actually reduce colonic butyrate production by depleting fiber intake and diminishing butyrate-producing gut bacteria — the very diet designed to boost the "HDAC-inhibiting ketone" may be depleting the actual HDAC inhibitor
- While BHB has legitimate benefits as an alternative fuel source and GPR109A receptor activator, the widespread claim that ketosis provides "epigenetic therapy" through HDAC inhibition appears to be scientifically unfounded
You May Also Like

The Healthy Diabetic
Coach Ken Kniss

The Coach JV Podcast
Coach JV | Age of Radio Original

The Kris Krohn Show
Kris Krohn

Radio Headspace
Headspace Studios

Mental Illness Happy Hour
Paul Gilmartin

Meditative Prayers by Pray.com
iHeartPodcasts and Pray.com

Sex and Psychology Podcast
Dr. Justin Lehmiller

Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio

The Robert Scott Bell Show
Don Naylor

The Alpha Mind | Daily Affirmations
Motivation
Community discussion